Evidence map›Paper›PMID 42348330›Full record

ArticleJournal of inherited metabolic disease2026

Long Term Follow-Up After Transplantation in Propionic Acidemia: A Retrospective French Pediatric and Adult Cohort Study.

Tristan Mekdade, Claire-Marine Bérat, Manuel Schiff, Margaux Gaschignard, Juliette Bouchereau, Jean-Baptiste Arnoux, Claire Francoz, Aude Servais, Myriam Dao, Vickie Lacroix and 16 more

Abstract read
In one paragraph

Article in Journal of inherited metabolic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Tristan MekdadeReference Center of Inherited Metabolic Diseases, Necker Enfants Malades Hospital, APHP, Université Paris Cité, Paris, France.ORCID https://orcid.org/0000-0002-5223-332X
Claire-Marine BératReference Center of Inherited Metabolic Diseases, Necker Enfants Malades Hospital, APHP, Université Paris Cité, Paris, France.ORCID https://orcid.org/0000-0001-9861-3179
Manuel SchiffReference Center of Inherited Metabolic Diseases, Necker Enfants Malades Hospital, APHP, Université Paris Cité, Paris, France.ORCID https://orcid.org/0000-0001-8272-232X
Margaux GaschignardReference Center of Inherited Metabolic Diseases, Necker Enfants Malades Hospital, APHP, Université Paris Cité, Paris, France.
Juliette BouchereauReference Center of Inherited Metabolic Diseases, Necker Enfants Malades Hospital, APHP, Université Paris Cité, Paris, France.
Jean-Baptiste ArnouxReference Center of Inherited Metabolic Diseases, Necker Enfants Malades Hospital, APHP, Université Paris Cité, Paris, France.
Claire FrancozHepatology Unit, Beaujon Hospital, APHP, Paris, France.ORCID https://orcid.org/0000-0001-7391-8507
Aude ServaisNephrology Unit, Necker Enfants Malades Hospital, APHP, Université Paris Cité, Paris, France.
Myriam DaoNephrology Unit, Necker Enfants Malades Hospital, APHP, Université Paris Cité, Paris, France.
Vickie LacroixPediatric Gastroenterology, Hepatology and Metabolic Disease, Toulouse University Hospital, Toulouse, France.
Julien MaquetInternal Medicine, Toulouse University Hospital, Toulouse, France.ORCID https://orcid.org/0000-0002-2187-9435
Apolline ImbardBiochemistry Department, Necker-Enfants Malades University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.ORCID https://orcid.org/0000-0002-0420-8322
Edouard Le GuillouBiochemistry Department, Necker-Enfants Malades University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
Clément PontoizeauBiochemistry Department, Necker-Enfants Malades University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
Jean-François BenoistBiochemistry Department, Necker-Enfants Malades University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.ORCID https://orcid.org/0000-0002-5389-8585
Mehdi OualhaPediatric Intensive Care Unit, Necker Enfants Malades Hospital, APHP, Paris Cité University, Paris, France.
Marion GrimaudPediatric Intensive Care Unit, Necker Enfants Malades Hospital, APHP, Paris Cité University, Paris, France.
Charles de MarcellusPediatric Intensive Care Unit, Necker Enfants Malades Hospital, APHP, Paris Cité University, Paris, France.ORCID https://orcid.org/0000-0003-3935-0924
Laurent SabbahAdult Cardiology Unit, Necker Enfants Malades Hospital, APHP, Université Paris Cité, Paris, France.
Claire MayerPediatric Gastroenterology-Nutrition and Hepatology Units, Necker Enfants Malades Hospital, APHP, Université Paris Cité, Paris, France.
Christophe ChardotPediatric Liver Surgery, Necker Enfants Malades Hospital, APHP, Université Paris Cité, Paris, France.ORCID https://orcid.org/0000-0002-3248-5650
Carmen CapitoPediatric Liver Surgery, Necker Enfants Malades Hospital, APHP, Université Paris Cité, Paris, France.
Diala KhraichePediatric Cardiology Unit, Necker Enfants Malades Hospital, APHP, Université Paris Cité, Paris, France.
Florence LacaillePediatric Gastroenterology-Nutrition and Hepatology Units, Necker Enfants Malades Hospital, APHP, Université Paris Cité, Paris, France.
Pascale de LonlayReference Center of Inherited Metabolic Diseases, Necker Enfants Malades Hospital, APHP, Université Paris Cité, Paris, France.
Anaïs BrassierReference Center of Inherited Metabolic Diseases, Necker Enfants Malades Hospital, APHP, Université Paris Cité, Paris, France.ORCID https://orcid.org/0000-0002-9528-3546

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Propionic acidemia (PA) is a rare inherited metabolic disorder associated with recurrent metabolic decompensations and chronic multisystemic complications. Liver transplantation (LT) may improve metabolic stability, but its long-term impact on organ involvement remains debated. We retrospectively studied 20 patients with PA transplanted between 1993 and 2024 in three French reference centers. Clinical, biochemical, and organ-specific data were collected before and after transplantation. Eighteen isolated LT and two combined liver-kidney transplantations were performed. Median age at transplantation was 13.6 years; median follow-up was 4.5 years. Indications included frequent metabolic decompensation (70%) and cardiomyopathy (35%). Four patients died perioperatively, three from cardiac causes; crude survival was 75%. Transplantation markedly improved metabolic stability and allowed significant dietary liberalization, with reduced need for enteral feeding. Cardiac involvement, present in 15 patients pre-transplant, showed variable evolution: 10 improved initially, but three deteriorated later, and one required heart transplantation. New neurological manifestations occurred in eight patients, with acute episodes including CNI-related encephalopathy. Psychiatric disorders progressed from 40% to 59% of patients, requiring treatment in seven. Renal impairment worsened post-LT to 70%, with mean measured glomerular filtration rate declining from 72 to 60 mL/min/1.73 m

Indexed as

Kidney TransplantationLiver TransplantationPropionic AcidemiaAdolescentAdultChildChild, PreschoolFemaleFollow-Up StudiesFranceHumansMaleRetrospective StudiesTreatment OutcomeYoung AdultcardiomyopathyLeigh syndromeliver transplantationpropionic acidemiapsychiatric manifestations

Identifiers

PMID42348330
PMCPMC13297872

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.